HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Sven Borchmann Selected Research
Sven Borchmann Research Topics
Disease
16
Neoplasms (Cancer)
02/2024 - 06/2014
15
Hodgkin Disease (Hodgkin's Disease)
01/2023 - 01/2016
3
Residual Neoplasm
02/2024 - 12/2020
3
Lymphoma (Lymphomas)
11/2023 - 12/2020
2
Lung Neoplasms (Lung Cancer)
01/2020 - 01/2018
1
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
08/2022
1
Neoplasm Metastasis (Metastasis)
01/2020
1
Vitamin D Deficiency
12/2019
1
Obesity
01/2019
1
Acquired Immunodeficiency Syndrome (AIDS)
01/2019
1
Breast Neoplasms (Breast Cancer)
10/2018
1
Small Cell Lung Carcinoma (Small Cell Lung Cancer)
01/2018
1
Disease Progression
11/2017
1
Carcinoma (Carcinomatosis)
06/2014
Drug/Important Bio-Agent (IBA)
5
DNA (Deoxyribonucleic Acid)
IBA
02/2024 - 12/2020
5
Circulating Tumor DNA
IBA
11/2023 - 01/2020
5
Antibodies
IBA
10/2022 - 08/2014
5
Cell-Free Nucleic Acids
IBA
06/2022 - 09/2017
5
Proteins (Proteins, Gene)
FDA Link
01/2022 - 06/2014
2
Biomarkers (Surrogate Marker)
IBA
11/2023 - 01/2020
2
Antigens
IBA
10/2022 - 01/2022
2
RNA (Ribonucleic Acid)
IBA
10/2022 - 01/2021
2
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
01/2020 - 01/2018
2
Vitamin D
FDA Link
Generic
12/2019 - 11/2017
2
Immune Checkpoint Inhibitors
IBA
09/2017 - 01/2016
1
ruxolitinib
IBA
12/2022
1
Epitopes
IBA
10/2022
1
Toll-Like Receptor 3
IBA
10/2022
1
Erlotinib Hydrochloride (CP 358,774)
FDA Link
08/2022
1
osimertinib
IBA
08/2022
1
B7-H1 Antigen
IBA
01/2022
1
Dexamethasone (Maxidex)
FDA Link
Generic
01/2022
1
Everolimus
FDA Link
01/2022
1
Interferons
IBA
01/2021
1
Phosphotransferases (Kinase)
IBA
01/2021
1
Programmed Cell Death 1 Receptor
IBA
12/2020
1
Chimeric Antigen Receptors
IBA
11/2020
1
Serine (L-Serine)
FDA Link
01/2020
1
Cholecalciferol (Vitamin D3)
FDA Link
12/2019
1
Nivolumab
IBA
10/2019
1
infigratinib
IBA
10/2018
1
Mitogen-Activated Protein Kinase Kinases (MEKs)
IBA
10/2018
1
Brentuximab Vedotin
IBA
01/2016
1
Bleomycin (Blenoxane)
FDA Link
Generic
01/2016
1
Monoclonal Antibodies
IBA
08/2014
1
Carcinoembryonic Antigen
IBA
06/2014
1
Ligands
IBA
06/2014
1
Recombinant Fusion Proteins
IBA
06/2014
Therapy/Procedure
8
Therapeutics
12/2022 - 08/2014
5
Drug Therapy (Chemotherapy)
01/2022 - 01/2018
2
Immunotherapy
10/2022 - 08/2014
1
Aftercare (After-Treatment)
10/2021
1
Radiotherapy
01/2019